Our data have led us to hypothesize that CRC cells without PTPRS are more sensitive to MEK or ERK inhibition because, unlike the parental cells, they cannot invoke an adaptive resistance response that bypasses MEK/ERK drug blockade. Here, PTPRS is linked to colorectal carcinoma.